Tryton Announces Investigational Device Exemption Conditional Approval from FDA to Conduct U.S. Pivotal Study of Side Branch Stent Study to Enroll 700 Patients At Up To 75 Centers in North America and Europe

December 2, 2010:
Tryton Announces Investigational Device Exemption Conditional Approval from
FDA to Conduct U.S. Pivotal Study of Side Branch Stent
Study to Enroll 700 Patients At Up To 75 Centers in North America and Europe
Download PDF